IDXX
2024Q4BMOIDEXX Laboratories Inc primary · HEALTHCARE · DIAGNOSTICS & RESEARCH
Street
Consensus EPS2.40
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—
Options
Implied move4.1%
IV front—
P/C full—
P/C front—
Features as of2025-01-31
Run-up
Close—
Ret 5d-3.1%
Ret 10d-1.5%
Ret 20d+2.1%
Ret 30d-2.0%
Actual EPS
2.62Beat
Estimated EPS2.40
Actual revenue
954.3M
Surprise %+9.2%
Beat / missBeat
Beat streak 44
Beat streak 88
Reaction
1-day stock reaction+0.9%
Implied vs actual
Implied 4.1%Actual 10.2%
Gap reaction+10.2%
Day result+11.1%
Next-day upYes
Realized / IV2.50×
Post tape
Post 5d-0.9%
Post 10d-4.3%
Post volume1.5M
Vol ×10d1.74×
Vol ×20d2.17×
Post range6.4%